Literature DB >> 31832441

The Effect of Low Testosterone and Estrogen Levels on Progressive Coronary Artery Disease in Men.

Mansoureh Bajelan1, Negar Etehad Roodi1,2, Mahdy Hasanzadeh Daloee3, Mansoureh Farhangnia2, Ali Samadi Kuchaksaraei1,2.   

Abstract

BACKGROUND: Age-related morbidity and mortality rates from coronary heart disease (CHD) are higher in men than in women. Abnormal androgen levels cause a variety of abnormal symptoms in men. Testosterone and estrogen are the main sex hormone in men and women, respectively, and studies have shown that they have important roles in cardiovascular health and disease.
METHODS: We measured testosterone and estrogen in 102 men with coronary heart disease and 45 controls. Blood samples were collected from subjects and plasma testosterone and estrogen were measured by ELISA.
RESULTS: Men with coronary heart disease had less testosterone (OD Ratio: 0.782) and estrogen (OD Ratio: 0.955) than controls.
CONCLUSION: Low testosterone and estrogen levels correlate with coronary artery disease.

Entities:  

Keywords:  Coronary artery disease; Estrogen; Testosterone

Year:  2019        PMID: 31832441      PMCID: PMC6844610     

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  10 in total

1.  Testosterone supplementation and cardiovascular risk.

Authors:  Giovanni Corona; Mario Maggi
Journal:  Trends Cardiovasc Med       Date:  2014-11-08       Impact factor: 6.677

2.  A critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men.

Authors:  Jason Scovell; Ranjith Ramasamy; Jason R Kovac
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

3.  Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial.

Authors:  Grace Huang; Elizabeth Tang; Adam Aakil; Stephan Anderson; Hernan Jara; Maithili Davda; Helene Stroh; Thomas G Travison; Shalender Bhasin; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2014-04-08       Impact factor: 5.958

Review 4.  Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.

Authors:  Giovanni Corona; Elisa Maseroli; Giulia Rastrelli; Andrea M Isidori; Alessandra Sforza; Edoardo Mannucci; Mario Maggi
Journal:  Expert Opin Drug Saf       Date:  2014-08-19       Impact factor: 4.250

5.  Differential effects of estrogen and testosterone on auditory sensory gating in rats.

Authors:  Shane J Thwaites; Maarten van den Buuse; Andrea Gogos
Journal:  Psychopharmacology (Berl)       Date:  2013-08-09       Impact factor: 4.530

Review 6.  Testosterone therapy and cardiovascular risk.

Authors:  James P Walsh; Anne C Kitchens
Journal:  Trends Cardiovasc Med       Date:  2014-10-28       Impact factor: 6.677

Review 7.  [Testosterone: a treatment for the prevention of cardiovascular disease].

Authors:  B Gencer; B Köhler Ballan; J Philippe; F Mach
Journal:  Rev Med Suisse       Date:  2014-05-28

8.  Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study.

Authors:  Molly M Shores; Mary L Biggs; Alice M Arnold; Nicholas L Smith; W T Longstreth; Jorge R Kizer; Calvin H Hirsch; Anne R Cappola; Alvin M Matsumoto
Journal:  J Clin Endocrinol Metab       Date:  2014-03-14       Impact factor: 5.958

9.  Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.

Authors:  Avinash Maganty; E Charles Osterberg; Ranjith Ramasamy
Journal:  Am J Mens Health       Date:  2014-06-26

10.  The putative mechanisms underlying testosterone and cardiovascular risk.

Authors:  Avinash Maganty; Jason R Kovac; Ranjith Ramasamy
Journal:  F1000Res       Date:  2014-04-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.